Literature DB >> 17050501

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting.

Eric R Braverman1, Thomas J H Chen, John Schoolfield, Manuel Martinez-Pons, Vanessa Arcuri, Michael Varshavskiy, Cory A Gordon, Julie Mengucci, Seth H Blum, Brian Meshkin, Bernard W Downs, Kenneth Blum.   

Abstract

Delayed P300 latency identifies dementia better than the Mini-Mental Status Exam and, in some cases, the Wechsler Memory Scale (WMS-III). The purpose of this study was to determine whether the outcome of an objective Test of Variables of Attention (TOVA) correlates with the findings of an electrophysiologic test-P300 latency-in patients 40 y of age or older. Adult attention deficit disorder may be an important premorbid marker of memory dysfunction or dementia. In males, the means for P300 latency and age-adjusted P300 latency were significantly greater for patients classified as SD-BL (significantly deviant or borderline: TOVA<-1.0) than for those categorized as normal (TOVA(3)0) for attention failure (ie, omissions [P<.010] and commissions [P<.005]) but not for response time or for variability. Males with >2 SD-BL quarters had significantly delayed P300 latency and age-adjusted P300 latency compared with males who had 0 SD-BL quarters (P<.020) and 1 SD-BL quarter (P<.005). In females, the means for P300 latency and age-adjusted P300 latency were significantly delayed for those grouped as SD-BL than for those labeled normal for response time (P<.001) and variability (P<.010), but not for omissions or for commissions. Females with >2 SD-BL quarters had significantly delayed P300 latency and age-adjusted P300 latency compared with females who had 0 SD-BL quarters (P<.005) and 1 SD-BL quarter (P<.010). Results suggest that TOVA abnormalities may be an indicator of delayed P300 and attention disorder. Recent research correlates TOVA abnormalities with impaired WMS scores of early dementia. Coupling of TOVA assessment findings with results of P300, Mini-Mental Status Exam, and WMS-III may allow for enhanced accuracy in the diagnosis and evaluation of the complex pathway of failing attention, memory, and cognition that leads to dementia.

Entities:  

Mesh:

Year:  2006        PMID: 17050501     DOI: 10.1007/bf02850047

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  11 in total

1.  Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people.

Authors:  E Cetin; E C Top; G Sahin; Y G Ozkaya; H Aydin; F Toraman
Journal:  J Nutr Health Aging       Date:  2010-11       Impact factor: 4.075

2.  Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".

Authors:  Eric R Braverman; Catherine A Dennen; Mark S Gold; Abdalla Bowirrat; Ashim Gupta; David Baron; A Kenison Roy; David E Smith; Jean Lud Cadet; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

3.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

4.  Vanadium exposure-induced neurobehavioral alterations among Chinese workers.

Authors:  Hong Li; Dinglun Zhou; Qin Zhang; Chengyong Feng; Wei Zheng; Keping He; Yajia Lan
Journal:  Neurotoxicology       Date:  2013-03-07       Impact factor: 4.294

5.  Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia.

Authors:  Eric R Braverman; Amanda Lih-Chuan Chen; Thomas J H Chen; John D Schoolfield; Alison Notaro; Dasha Braverman; Mallory Kerner; Seth H Blum; Vanessa Arcuri; Michael Varshavskiy; Uma Damle; B William Downs; Roger L Waite; Marlene Oscar-Berman; John Giordano; Kenneth Blum
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-15       Impact factor: 2.570

6.  Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Patterns.

Authors:  Mario Vitali; Carmen Napolitano; Marlene Oscar Berman; Simona Flamminii Minuto; Gemma Battagliese; Maria Luisa Attilia; Eric R Braverman; Marina Romeo; Kenneth Blum; Mauro Ceccanti
Journal:  J Addict Res Ther       Date:  2016-04-26

7.  Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?

Authors:  Thomas McLaughlin; David Han; James Nicholson; Bruce Steinberg; Kenneth Blum; Marcelo Febo; Eric Braverman; Mona Li; Lyle Fried; Rajendra Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2017-06-17

8.  The Effect of Adding Transcranial Direct Current Stimulation to Hyperbaric Oxygen Therapy in Patients With Delayed Encephalopathy After Carbon Monoxide Poisoning: A Randomised Controlled Trial.

Authors:  Huifang Cao; Xiaona Tan; Zibo Liu; Long Zhao; Lin Chi; Manyu Li; Chunhui Liu; Hongling Li
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

9.  Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients.

Authors:  Eric R Braverman; Kenneth Blum; Uma J Damle; Mallory Kerner; Kristina Dushaj; Marlene Oscar-Berman
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  Attention-deficit-hyperactivity disorder and reward deficiency syndrome.

Authors:  Kenneth Blum; Amanda Lih-Chuan Chen; Eric R Braverman; David E Comings; Thomas J H Chen; Vanessa Arcuri; Seth H Blum; Bernard W Downs; Roger L Waite; Alison Notaro; Joel Lubar; Lonna Williams; Thomas J Prihoda; Tomas Palomo; Marlene Oscar-Berman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.